After eight years involvement with the Mid Europa team, Colin Hewett has stepped down from the investment and management committees of Mid Europa Partners. Although Hewett has decided to pursue other interests, he will continue as a consultant to the firm.
Also backing the biotech startup were the Zürcher Kantonalbank and Greencross Medical Science Corp
Company plans to use the fresh capital to further expand, develop new features and scale up its team
EVentures, 468 Capital and HV Holtzbrinck back the round for the climate change mitigation app
Clessidra has been in negotiations for the acquisition of the Italian wine producer since February 2020